Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Gastric cancer shows a male predominance that might be explained by protective effects from estrogens in females. Two Lauren classification histological subtypes, intestinal and diffuse, have distinct carcinogeneses. The purpose of this study was to estimate the effects of sex hormone on female gastric cancer according to Lauren classification. Materials and Methods: We reviewed medical records for and administered questionnaires, surveying reproductive and hormonalfactors, to 758 patients who underwent gastrectomy for gastric cancer at Samsung Medical Center from May 2012 to November2014. Clinicopathological characteristics were compared between females and males. The incidence of intestinal-type gastric cancer was compared between females subgroups, consist of premenopausal women and three groups of postmenopausalwomen (five-year intervals after menopause), and males. The association between reproductive factors and intestinal-type gastric cancer was analyzed by multivariate models for the female group. Results: In total, 227 females (29.9%) and 531 males (70.9%) were included in the analysis. Undifferentiated adenocarcinoma and diffuse-type histology were more frequent in female patients than male patients. While 221 (41.6%) male patients had intestinal-type gastric cancer, no premenopausal female patient had this type of gastric cancer. The incidence of intestinal-type gastric cancerincreased with time after menopause, and was similar to males after 10 years from menopause. Parity was associated with an increased risk of intestinal-type gastric cancer in menopausal women. Conclusion: These findings support that female sex hormones might be protective against intestinal-type gastric cancer.
Abstract
Purpose: Gastric cancer shows a male predominance that might be explained by protective effects from estrogens in females. Two Lauren classification histological subtypes, intestinal and diffuse, have distinct carcinogeneses. The purpose of this study was to estimate the effects of sex hormone on female gastric cancer according to Lauren classification. Materials and Methods: We reviewed medical records for and administered questionnaires, surveying reproductive and hormonalfactors, to 758 patients who underwent gastrectomy for gastric cancer at Samsung Medical Center from May 2012 to November2014. Clinicopathological characteristics were compared between females and males. The incidence of intestinal-type gastric cancer was compared between females subgroups, consist of premenopausal women and three groups of postmenopausalwomen (five-year intervals after menopause), and males. The association between reproductive factors and intestinal-type gastric cancer was analyzed by multivariate models for the female group. Results: In total, 227 females (29.9%) and 531 males (70.9%) were included in the analysis. Undifferentiated adenocarcinoma and diffuse-type histology were more frequent in female patients than male patients. While 221 (41.6%) male patients had intestinal-type gastric cancer, no premenopausal female patient had this type of gastric cancer. The incidence of intestinal-type gastric cancerincreased with time after menopause, and was similar to males after 10 years from menopause. Parity was associated with an increased risk of intestinal-type gastric cancer in menopausal women. Conclusion: These findings support that female sex hormones might be protective against intestinal-type gastric cancer.
참고문헌 (24)
- Ferlay J, "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)[DOI]
- Cancer incidence in five continents, CI5plus, "Forman D BF", International Agency for Research on Cancer, ~, pp.IARC CancerBase No. 9 (2014)
- Freedman ND, "Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women", Gut, 56, pp.1671~1677 (2007)[DOI]
- Chandanos E, "Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden", Br J Cancer, 95, pp.118~122 (2006)[DOI]
- Helguero LA, "Different roles of estrogen receptors alpha and beta in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line", Cancer Res, 68, pp.8695~8704 (2008)[DOI]
- Lauren P, "The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification", Acta Pathol Microbiol Scand, 64, pp.31~49 (1965)[DOI]
- Ribeiro MM, "Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma", Cancer, 47, pp.780~784 (1981)[DOI]
- Gurzu S, "Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity", APMIS, 123, pp.223~233 (2015)[DOI]
- Edge SB, "AJCC cancer staging manual. 7th ed" (2010), Springer
- Yang H, "Estrogen, male dominance and esophageal adenocarcinoma: is there a link?", World J Gastroenterol, 18, pp.393~400 (2012)[DOI]
- Beral V, "Breast cancer and hormone-replacement therapy in the Million Women Study", Lancet, 362, pp.419~427 (2003)[DOI]
- Beral V, "Endometrial cancer and hormone-replacement therapy in the Million Women Study", Lancet, 365, pp.1543~1551 (2005)[DOI]
- Lacey JV Jr, "Menopausal hormone replacement therapy and risk of ovarian cancer", JAMA, 288, pp.334~341 (2002)[DOI]
- Poulter NR, "Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception", Lancet, 349, pp.1202~1209 (1997)[DOI]
- Grady D, "Hormone replacement therapy and endometrial cancer risk: a metaanalysis", Obstet Gynecol, 85, pp.304~313 (1995)[DOI]
- Grodstein F, "Postmenopausal hormone therapy and the risk of colorectal cancer: a review and metaanalysis", Am J Med, 106, pp.574~582 (1999)[DOI]
- Lindblad M, "Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden", Cancer Epidemiol Biomarkers Prev, 13, pp.2203~2207 (2004)
- Curtis RE, "Second cancers after adjuvant tamoxifen therapy for breast cancer", J Natl Cancer Inst, 88, pp.832~834 (1996)[DOI]
- Furukawa H, "Effect of sex hormones on the experimental induction of cancer in rat stomach-a preliminary study", Digestion, 23, pp.151~155 (1982)[DOI]
- Sipponen P, "Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M", F) pattern: etiologic hypothesis, 2002, pp.5, 213~219
- Qiu MZ, "Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China", Tumour Biol, 32, pp.509~514 (2011)[DOI]
- Chandanos E, "Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma", Gastric Cancer, 11, pp.168~174 (2008)[DOI]
- Ibrahim A, "Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: systematic review and meta-analysis of 244 studies", Dig Liver Dis, 49, pp.742~749 (2017)[DOI]
- Yi JH, "Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer", Sci Rep, 4, pp.7592~ (2014)